AbCellera Biologics Inc (NASDAQ:ABCL) price on current trading day, rose 1.70% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $2.39. A look at the stock’s price movement, the close in the last trading session was $2.35, moving
AbCellera Biologics Inc (NASDAQ:ABCL) price closed higher on Monday, March 17, and jumping 0.79% above its previous close. A look at the daily price movement shows that the last close reads $2.52, with intraday deals fluctuated between $2.4001 and $2.55. The company’s 5Y monthly beta
AbCellera Biologics Inc (NASDAQ:ABCL) concluded the trading at $2.40 on Thursday, March 13 with a rise of 2.13% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $2.35 and 5Y monthly beta
AbCellera Biologics Inc (NASDAQ:ABCL) traded at $2.33 at close of the session on Friday, March 07 and made a downward move of -2.10% on its previous day’s price. AbCellera Biologics Inc has a market cap of $694.31 million and is expected to release its quarterly
AbCellera Biologics Inc (NASDAQ:ABCL) shares, rose in value, with the stock price up by 2.14% to the previous day’s close as strong demand from buyers drove the stock to $2.39. Actively observing the price movement in the last trading, the stock closed the session at
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
